O. Gansow

发表

Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant

T. Yokota, P. Hand, J. Schlom, 2005, Cancer Immunology, Immunotherapy.

Lead(II) and bismuth(III) complexes of the polyazacycloalkane-N-acetic acids nota, dota, and teta

Krishan Kumar, O. Gansow, M. Magerstadt, 1989 .

Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.

I. Pastan, M. Brechbiel, K. Garmestani, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A carbon-13 and proton magnetic resonance examination of solute structures, equilibriums, and structural interconversions in some dinuclear .eta.5-dienylruthenium, -iron, and -nickel carbonyls

O. Gansow, A. Burke, W. Vernon, 1976 .

Rhodium-103 NMR evidence for charge separation and fluxionality among rhodium atoms in metal clusters

J. Vidal, O. Gansow, R. C. Schoening, 1980 .

Synthesis and chemical properties of lanthanide cryptates

M. J. Weaver, O. Gansow, A. Kausar, 1977 .

Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies.

S. Mirzadeh, M. Brechbiel, J. Schlom, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Comparison of five bifunctional chelate techniques for 90Y-labeled monoclonal antibody CO17-1A.

M. Brechbiel, O. Gansow, M. Stabin, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.

T. Waldmann, S. Mirzadeh, M. Brechbiel, 1989, Cancer research.

Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.

S. Mirzadeh, M. Brechbiel, J. Schlom, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Metal-chelate-dendrimer-antibody constructs for use in radioimmunotherapy and imaging

Martin W. Brechbiel, M. Brechbiel, O. Gansow, 1994 .

Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies

D. E. Simpson, M. Brechbiel, J. Schlom, 1986 .

Convenient synthesis of bifunctional tetraaza macrocycles.

M. Brechbiel, O. Gansow, T. McMurry, 1992, Bioconjugate chemistry.

Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1 B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA)

I. Pastan, M. Brechbiel, J. Carrasquillo, 1994, European Journal of Nuclear Medicine.

T. Waldmann, M. Brechbiel, J. Carrasquillo, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand

M. Brechbiel, J. Schlom, J. Carrasquillo, 1998, European Journal of Nuclear Medicine.

Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies.

I. Pastan, M. Brechbiel, J. Carrasquillo, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Stereochemical influence on the stability of radio-metal complexes in vivo. Synthesis and evaluation of the four stereoisomers of 2-(p-nitrobenzyl)-trans-CyDTPA.

I. Pastan, M. Brechbiel, J. Carrasquillo, 1997, Bioorganic & medicinal chemistry.

Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses.

L. Kostakoglu, K. Garmestani, O. Gansow, 1996, Nuclear medicine and biology.

Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates.

O. Gansow, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Selection of a dtpa chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice

M. Brechbiel, G. Griffiths, O. Gansow, 1990, International journal of cancer.

New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.

D. E. Simpson, M. Brechbiel, J. Schlom, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Preclinical evaluation of 111In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts.

I. Pastan, M. Brechbiel, J. Carrasquillo, 1993, Cancer research.

Radioimmunotherapy of Nude Mice Bearing a Human Interleukin 2 Receptor α-expressing Lymphoma Utilizing the α-emitting Radionuclide-conjugated Monoclonal Antibody 212Bi-anti-Tac

T. Waldmann, M. Brechbiel, K. Garmestani, 1994 .

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies.

D. Scheinberg, M. Brechbiel, O. Gansow, 1995, Nuclear medicine and biology.

Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias.

S. Larson, D. Scheinberg, R. Warrell, 1995, Cancer research.

Localization of pulmonary human sarcoma xenografts in athymic nude mice with indium-111-labeled monoclonal antibodies.

M. Brechbiel, T. K. Das Gupta, O. Gansow, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The Interleukin‐2 Receptor: A Target for Immunotherapy

T. Waldmann, B. Mishra, C. Goldman, 1993, Annals of the New York Academy of Sciences.

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.

T. Waldmann, A. M. Friedman, O. Gansow, 1986, Proceedings of the National Academy of Sciences of the United States of America.

In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates.

S. Mirzadeh, M. Brechbiel, J. Schlom, 2001, Cancer biotherapy & radiopharmaceuticals.

Effective α-Particle-mediated Radioimmunotherapy of Murine Leukemia

M. Brechbiel, O. Gansow, R. Squire, 1992 .

Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo.

M. Brechbiel, M. Welch, O. Gansow, 1995, Magnetic resonance imaging.

Accumulation of indium-111-labeled human low density lipoprotein in the rabbit aorta: Implications for nuclear imaging of vascular lesions.

O. Gansow, D. Casalino, R. Fleming, 1992, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Radionuclide-conjugated monoclonal antibodies: a synthesis of immunology, inorganic chemistry and nuclear science

T. Waldmann, O. Gansow, R. Atcher, 1986 .

Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.

A. Chang, J. Carrasquillo, M. Roselli, 1989, Journal of Nuclear Medicine.

Generator-Produced Bi-212: Chelated to Chemically Modified Monoclonal Antibody for Use in Radiotherapy

D. Scheinberg, D. Link, A. M. Friedman, 1984 .

An effective chelating agent for labelling of monoclonal antibody with 212Bi for α-particle mediated radioimmunotherapy

M. Brechbiel, M. Roselli, D. Milenic, 1991 .

Alpha particle emitting constructs of recomblnant humanized antl-CD33 for myelold teukemlas

D. Scheinberg, O. Gansow, C. Apostolidis, 1994 .

212Bismuth linked to an antipancreatic carcinoma antibody: model for alpha-particle-emitter radioimmunotherapy.

M. Brechbiel, A. M. Friedman, S. Kurtzman, 1988, Journal of the National Cancer Institute.

Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.

A. Scott, E. Riedel, L. Old, 1998, International journal of oncology.

Chelates and antibodies: current methods and new directions.

S. Mirzadeh, M. Brechbiel, M. Roselli, 1990, Cancer treatment and research.

Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targets.

T. Waldmann, O. Gansow, W. Eckelman, 1998, Nuclear medicine and biology.

Evaluation of methods for large scale preparation of antibody ligand conjugates.

M. Brechbiel, O. Gansow, C. Wu, 1999, Nuclear medicine and biology.

In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts.

S. Mirzadeh, M. Brechbiel, J. Schlom, 1999, Cancer biotherapy & radiopharmaceuticals.

Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents

P C Lauterbur, R L Magin, E C Wiener, 1994, Magnetic resonance in medicine.

Lead(II) complexes of 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetate: solution chemistry and application to tumor localization with 203Pb labeled monoclonal antibodies

M. Brechbiel, M. Roselli, D. Milenic, 1995 .

Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteins.

I. Pastan, M. Brechbiel, J. Carrasquillo, 1997, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation.

T. Waldmann, S. Mirzadeh, M. Brechbiel, 1990, Transplantation.

The preparation and X-ray crystallographic characterization of lead(II) calix[4]arenesulfonate complex

M. Brechbiel, R. Rogers, O. Gansow, 1999 .

Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.

T. Waldmann, M. Brechbiel, K. Garmestani, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vitro and in vivo evaluation of structure-stability relationship of 111In- and 67Ga-labeled antibody via 1B4M or C-NOTA chelates.

M. Brechbiel, J. Carrasquillo, C. Choi, 1997, Nuclear medicine and biology.

Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood.

M. Brechbiel, T. Saga, J. Carrasquillo, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Improved sarcoma imaging and reduced hepatic activity with indium-111-SCN-Bz-DTPA linked to MoAb 19-24.

M. Brechbiel, J. Brown, T. K. Das Gupta, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Purification of p-nitrobenzyl C-functionalized diethylenetriamine pentaacetic acids for clinical applications using anion-exchange chromatography.

M. Brechbiel, O. Gansow, P. M. Beitzel, 1997, Journal of chromatography. A.

A direct synthesis of a bifunctional chelating agent for radiolabeling proteins

M. Brechbiel, O. Gansow, T. McMurry, 1993 .

Synthesis of 2-(p-thiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid: application of the 4-methoxy-2,3,6-trimethylbenzenesulfonamide protecting group in the synthesis of macrocyclic polyamines.

M. Brechbiel, O. Gansow, T. McMurry, 1993, Bioconjugate chemistry.

Difference in the biodistribution of indium and yttrium labelled monoclonal antibodies

S. Mirzadeh, M. Brechbiel, J. Schlom, 1989 .

Synthesis of 1-(p-Isothiocyanatobenzyl) Derivatives of DTPA and EDTA.

D. E. Simpson, M. Brechbiel, J. Schlom, 1986 .

Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy.

K. Garmestani, O. Gansow, S. Jones, 1996, Nuclear medicine and biology.

Effective alpha-particle-mediated radioimmunotherapy of murine leukemia.

M. Brechbiel, O. Gansow, R. Squire, 1992, Cancer research.

Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At.

T. Waldmann, M. Brechbiel, E. McGee, 2004, Nuclear medicine and biology.

Complexes of lanthanide nitrates with the Cryptand 2B:2:1

O. Gansow, A. Kausar, 1985 .

A ‘shiftless’ relaxation reagent for metal nuclide and nitrogen-15 magnetic resonance in aqueous solution†

John D. Roberts, O. Gansow, R. Botto, 1980 .

Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.

M. Brechbiel, K. Garmestani, O. Gansow, 1994, Cancer research.

Recovery of Bi-213 from an Ac-225 Cow: Application to the Radiolabeling of Antibodies with Bi-213

D. Scheinberg, M. Brechbiel, O. Gansow, 1995 .

Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibody.

T. Waldmann, I. Pastan, C. Goldman, 1990, Journal of immunology.

An Improved Generator for the Production of 213Bi from 225Ac

M. Brechbiel, O. Gansow, Chuanchu Wu, 1997 .

Preparation, 252Cf-plasma-desorption mass spectrometry and radiometal exchange of the Pb2+ and Bi3+ complexes of a hexalactam macrocycle.

L. Pannell, O. Gansow, M. Magerstadt, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy.

T. Waldmann, S. Mirzadeh, M. Brechbiel, 1993, Cancer research.

Design of ligands containing the o-hydroxybenzyl group. Metal-complexing properties of N,N″-bis(2-hydroxybenzyl)diethylenetriamine-N,N′,N″-triacetic acid

M. Brechbiel, E. Cukrowska, R. Hancock, 1994 .

Synthesis and characterization of some bifunctional 2b:2:1 cryptands

O. Gansow, A. Kausar, Kelly B. Triplett, 1981 .

Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin.

S. Mirzadeh, M. Brechbiel, O. Gansow, 1990, Bioconjugate chemistry.

Radiolabeled CHXB-2E4 is stable in vivo and is a suitable immunoconjugate for testing α-particle-emitting bismuth radionuclides in interleukin-2 receptor targeted immunotherapy

T. Waldmann, M. Brechbiel, K. Garmestani, 1994 .

Gd(DOTA): An alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy

M. Brechbiel, R. Knop, O. Gansow, 1986, Magnetic resonance in medicine.

Cerebrospinal fluid rhinorrhea: depiction with MR cisternography in dogs.

G. di Chiro, A. Dwyer, J. Frank, 1986, Radiology.

Improved in vivo stability and tumor targeting of bismuth-labeled antibody.

S. Mirzadeh, M. Brechbiel, O. Gansow, 1990, Cancer research.

The Chemical Fate of 212Bi-DOTA Formed by β- Decay of 212Pb(DOTA)2-***

S. Mirzadeh, Krishan Kumar, O. Gansow, 1993 .

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

T. Waldmann, E. Jaffe, M. Brechbiel, 1995, Blood.

The Multichain Interleukin-2 Receptor: A Target for Immunotherapy

T. Waldmann, I. Pastan, O. Gansow, 1988, Annals of Internal Medicine.

Backbone-substituted DTPA ligands for 90Y radioimmunotherapy.

M. Brechbiel, O. Gansow, 1991, Bioconjugate chemistry.

Gadolinium cryptelates as MR contrast agents.

A. Dwyer, J. Frank, R. Knop, 1987, Journal of computer assisted tomography.

Equilibria and solute structures in the aqueous systems pyridoxal-alanine-zinc(II) and -aluminum(III) as investigated by proton resonance

O. Gansow, R. H. Holm, 1969 .

Aqueous solution equilibria of pyridoxamine, pyridoxal, 3-hydroxypyridine-4-aldehyde, and 3-hydroxypyridine-2-aldehyde as studied by proton resonance

O. Gansow, R. H. Holm, 1968 .

Carbon magnetic resonance. Signal assignment by alternately pulsed nuclear magnetic resonance and lanthanide-induced chemical shifts

R. Lenkinski, O. Gansow, M. R. Willcott, 1971 .

Carbon-13 nuclear magnetic resonance spectra of some polycyanolefins and their transition metal derivatives

R. King, O. Gansow, A. Burke, 1974 .

Rate processes and carbon-13 magnetic resonance spectra. Hindered internal rotation of N,N-dimethyltrichloroacetamide

O. Gansow, A. Burke, J. Killough, 1971 .

Alternately pulsed carbon-13 and proton magnetic resonance, an alternative to nuclear off-resonance decoupling

O. Gansow, Werner Schittenheim, 1971 .

Temperature-dependent carbon-13 nuclear magnetic resonance spectra of the h5-cyclopentadienyliron dicarbonyl dimer, an application of a shiftless relaxation reagnet

O. Gansow, A. Burke, W. Vernon, 1972 .

Carbon-13 nuclear magnetic resonance of some Group VIb metal carbonyls and derivatives

Richard A. Brown, O. Gansow, G. Dobson, 1971 .

Correlation between infrared stretching frequencies and carbon-13 chemical shifts for some .pi.-cyclopentadienyliron carbonyls

O. Gansow, B. Y. Kimura, D. A. Schexnayder, 1972 .

Hypothesis of a bond alternation mechanism for charge delocalization which determines 183W chemical shifts in α[η5-C5H5)Ti(PW11O39)]4−

O. Gansow, W. Klemperer, R. Ho, 1980 .

A shiftless relaxation reagent for carbon-13 magnetic resonance of organometallic carbonyl compounds

O. Gansow, A. Burke, G. N. Mar, 1972 .

Characterization of the isomeric dialkylbarbituric acids formed by the reaction of barbiturates with diazoalkanes.

O. Gansow, D. Harvey, M. Horning, 1974, Biomedical mass spectrometry.

Contact vs. pseudocontact contributions to lanthanide-induced shifts in the nuclear magnetic resonance spectra of isoquinoline and of endo-norbornenol

Raymond E. Davis, R. Lenkinski, O. Gansow, 1976 .

Electrochemical studies of europium and ytterbium cryptate formation in aqueous solution. Effects of varying the metal oxidation state upon cryptate thermodynamics and kinetics

M. J. Weaver, O. Gansow, E. Yee, 1980 .

MOLECULAR DYNAMICS OF ION-CHELATE COMPLEXES ATTACHED TO DENDRIMERS

Martin W. Brechbiel, Paul C. Lauterbur, P. Lauterbur, 1996 .

Evaluation of lanthanide-induced carbon-13 contact vs. pseudocontact nuclear magnetic resonance shifts [7]

Raymond E. Davis, R. Lenkinski, O. Gansow, 1973 .

Dimethylene(2‐propenylidene)methanetricarbonyliron

W. E. Billups, O. Gansow, Lee-Phone Lin, 1972 .

Dimethylen(2-propenyliden)methantricarbonyleisen

W. E. Billups, O. Gansow, Lee-Phone Lin, 1972 .

MR cisternography and myelography with Gd-DTPA in monkeys.

R A Brooks, G Di Chiro, J. Doppman, 1985, Radiology.

Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies.

D. Scheinberg, O. Gansow, M. Strand, 1982, Science.

Ocular and cerebral metastases in the VX2 rabbit tumor model: contrast-enhanced MR imaging.

J. Doppman, A. Dwyer, J. Frank, 1987, Radiology.

Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3.

I. Pastan, M. Willingham, M. Brechbiel, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor.

E C Wiener, M. Brechbiel, S. Konda, 1997, Investigative radiology.

Preparation and in vivo evaluation of linkers for 211At labeling of humanized anti-Tac.

T. Waldmann, M. Brechbiel, Z. Zhang, 2001, Nuclear medicine and biology.

Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labelling of monoclonal antibodies with the bismuth-212 α-particle emitter

M. Brechbiel, O. Gansow, 1992 .

Evaluation of a new DTPA-derivative chelator: comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts.

I. Pastan, M. Brechbiel, J. Carrasquillo, 1993, Nuclear medicine and biology.

Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.

D. Scheinberg, M. Brechbiel, M. McDevitt, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.

W C Eckelman, E Jagoda, I. Pastan, 1997, Bioconjugate chemistry.

Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates.

S. Mirzadeh, M. Brechbiel, O. Gansow, 1998, Journal of medicinal chemistry.

Evidence for europium-induced fermi contact shifts in carbon-13 nuclear magnetic resonance spectra [8]

Raymond E. Davis, R. Lenkinski, O. Gansow, 1973 .

Continuous infusion chemotherapy as a radiation-enhancing agent for yttrium-90-radiolabeled monoclonal antibody therapy of a human tumor xenograft.

O. Gansow, D. Colcher, A. Raubitschek, 1994, Gynecologic oncology.

TRIVACANT HETEROPOLYTUNGSTATE DERIVATIVES: THE RATIONAL SYNTHESIS, CHARACTERIZATION, AND TUNGSTEN-183 NMR SPECTRA OF P2W18M4(H2O)2O6810- (M = COBALT,COPPER,ZINC)

O. Gansow, M. Droege, James R. Hutchinson, 1981 .

Iron-57 NMR: relaxation mechanisms and chemical shifts

O. Gansow, J. Hutchinson, E. Becker, 1984 .

57 Fe n.m.r. spectroscopy of heme proteins: chemical shift anisotropy and relaxation parameters of carbonylmyoglobin

O. Gansow, E. Becker, L. Baltzer, 1985 .

Preparation of the Novel Chelating Agent N-(2-Aminoethyl)-trans-1,2-diaminocyclohexane- N,N‘,N‘‘-pentaacetic Acid (H5CyDTPA), a Preorganized Analogue of Diethylenetriaminepentaacetic Acid (H5DTPA), and the Structures of BiIII(CyDTPA)2- and BiIII(H2DTPA) Complexes

Martin W. Brechbiel, Roy P. Planalp, M. Brechbiel, 1996 .